Replies to post #384451 on Anavex Life Sciences Corp (AVXL)

[boi568]

That's a remarkable attitude.

Let's say that Anavex reports all endpoints met, AF publishes some bogus attack, and the stock drops that day. You say you have been holding since 2015, but in this case you would sell half your shares rather than wait out a short attack. Do you think the share price would remain down on a successful AD 2b/3 trial? Do you think the company's decision to submit an NDA, or the FDA's decision on the application will be determined by a bogus short attack? And you have held, you say, for seven years for these kind of trial results? This doesn't add up.

[Jager997]

Welcome to the message board.

[tredenwater2]

Thanks for coming into the light. Great timing.

[Gator328]

Free advice is worth what you pay for it, but here goes: you should consider selling that half now because there's going to be more hit pieces, and based on his past history Dr. Missling will continue to ignore them as he should.

There may have been a time in 2015 or 2016 when Anavex's financial position was so tenuous that a blogger like Adam Feuerstein or Jean Fonteneau or Tim Sykes could harm the company, but those days are over. Anavex has a sufficient cash runway so even if the share price drops short-term, there's no immediate need for additional dilution.

If I could bet on the odds of there being a hit piece and a muted response, I'd wager the odds of positive data are over 50%, but the odds of a hit piece is closer to 95%.

[WolfofMia]

Never try to defend false aquations!

The data will speak for itself.

The stock price will not be moved by people who do not understand the impact of the data anyways.

Those that due and have the means will set the price, including taking advantage of those who do not understand.

[Bourbon_on_my_cornflakes]

NP: With a small biotech, merely having good science is not enough. The space is cutthroat, and the odds are stacked against small companies, which can be bled dry from a cash flow perspective by big pharma.

No problem. years worth of cash in the bank, AVXL cant be "bled dry" as long as results are good, since good results will mean approval and cash flow in a year or so, and big pharma will be begging to partner.

[abew4me]

Did you consider that TGD is, in fact, taking a proactive role by releasing all of the data at the same time?

Part of AF's strategy is to spread false information about the TLD. But if Anavex releases most (or all) of the data at the same time, it would make it very hard for AF to create a false narrative.

Just my two cents, fwiw.